View in EDS HTML Full Text PDF Full Text

Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.

Saved in:
Bibliographic Details
Title: Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
Authors: Reijers ILM; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Department of Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia., Rozeman EA; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Oncology Department, Royal North Shore Hospital, Sydney, Australia.; Oncology Department, Mater Hospital, Sydney, New South Wales, Australia., van Akkooi ACJ; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Wouters MW; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., van Houdt WJ; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Zuur CL; Department of Head and Neck Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, the Netherlands., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Klop WMC; Department of Head and Neck Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Oncology Department, Royal North Shore Hospital, Sydney, Australia.; Oncology Department, Mater Hospital, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Oncology Department, Royal North Shore Hospital, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., van de Wiel BA; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Blank CU; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam.; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Source: JAMA surgery [JAMA Surg] 2022 Apr 01; Vol. 157 (4), pp. 335-342.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589553 Publication Model: Print Cited Medium: Internet ISSN: 2168-6262 (Electronic) Linking ISSN: 21686254 NLM ISO Abbreviation: JAMA Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35138335
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reijers+ILM%22">Reijers ILM</searchLink>; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rawson+RV%22">Rawson RV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Colebatch+AJ%22">Colebatch AJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Department of Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Rozeman+EA%22">Rozeman EA</searchLink>; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Menzies+AM%22">Menzies AM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Oncology Department, Royal North Shore Hospital, Sydney, Australia.; Oncology Department, Mater Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22van+Akkooi+ACJ%22">van Akkooi ACJ</searchLink>; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Shannon+KF%22">Shannon KF</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wouters+MW%22">Wouters MW</searchLink>; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Saw+RPM%22">Saw RPM</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22van+Houdt+WJ%22">van Houdt WJ</searchLink>; Department of Surgical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zuur+CL%22">Zuur CL</searchLink>; Department of Head and Neck Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nieweg+OE%22">Nieweg OE</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Ch'ng+S%22">Ch'ng S</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Klop+WMC%22">Klop WMC</searchLink>; Department of Head and Neck Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Spillane+AJ%22">Spillane AJ</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Oncology Department, Royal North Shore Hospital, Sydney, Australia.; Oncology Department, Mater Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Oncology Department, Royal North Shore Hospital, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Scolyer+RA%22">Scolyer RA</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Tissue Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22van+de+Wiel+BA%22">van de Wiel BA</searchLink>; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Blank+CU%22">Blank CU</searchLink>; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology & Immunology, the Netherlands Cancer Institute, Amsterdam.; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101589553%22">JAMA surgery</searchLink> [JAMA Surg] 2022 Apr 01; Vol. 157 (4), pp. 335-342.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589553 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6262 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686254%22">21686254 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Surg <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35138335
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamasurg.2021.7554
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 335
    Titles:
      – TitleFull: Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reijers ILM
      – PersonEntity:
          Name:
            NameFull: Rawson RV
      – PersonEntity:
          Name:
            NameFull: Colebatch AJ
      – PersonEntity:
          Name:
            NameFull: Rozeman EA
      – PersonEntity:
          Name:
            NameFull: Menzies AM
      – PersonEntity:
          Name:
            NameFull: van Akkooi ACJ
      – PersonEntity:
          Name:
            NameFull: Shannon KF
      – PersonEntity:
          Name:
            NameFull: Wouters MW
      – PersonEntity:
          Name:
            NameFull: Saw RPM
      – PersonEntity:
          Name:
            NameFull: van Houdt WJ
      – PersonEntity:
          Name:
            NameFull: Zuur CL
      – PersonEntity:
          Name:
            NameFull: Nieweg OE
      – PersonEntity:
          Name:
            NameFull: Ch'ng S
      – PersonEntity:
          Name:
            NameFull: Klop WMC
      – PersonEntity:
          Name:
            NameFull: Spillane AJ
      – PersonEntity:
          Name:
            NameFull: Long GV
      – PersonEntity:
          Name:
            NameFull: Scolyer RA
      – PersonEntity:
          Name:
            NameFull: van de Wiel BA
      – PersonEntity:
          Name:
            NameFull: Blank CU
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2168-6262
          Numbering:
            – Type: volume
              Value: 157
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: JAMA surgery
              Type: main
ResultId 1